RTA 744 Injection in Patients With Leptomeningeal Disease

NCT00512460 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Study was closed due to loss of industry sponsorship

Conditions

Neoplastic Meningitis
Solid Tumor
Lymphoma
Leukemia
Brain Tumor

Interventions

DRUG: RTA 744

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]